Ben Teh
@benwtehID physician & clinician researcher @NCICancer @PeterMacCC. #infection #immuneprofiling #myeloma #vaccination
Similar User
@michyong2
@NCICancer
@ASIDANZ
@Josh_S_Davis
@AbbyPDouglas
@NCAS_Aus
@victoriahall26
@adm_stewart
@drdavidwjg
@brendanmcID
@TrubianoJason
@TransplantIDNet
@OrlaMorris61218
@TakaMatsuo_ID
@DhandAbhay
Poster presentations in session… presenting influenza-specific B & T cell analyses in pts w/ haematological malignancy - T cell responses preserved & less dependent on underlying disease and treatment regimen received. @NCICancer @kedzierskalab @id_austin @benwteh @options2024
Delighted to be part of @NCICancer @monicaslavin CRE to reduce the burden of infection in patients on new gen therapies.
Congratulations to the 20 new NHMRC’s Centres of Research Excellence that will share in an investment of $60 million announced today. Read our media release on our News Centre: ow.ly/NeRY50T0Nsx
Congratulations to the 20 new NHMRC’s Centres of Research Excellence that will share in an investment of $60 million announced today. Read our media release on our News Centre: ow.ly/NeRY50T0Nsx
Peter Mac has been awarded 3 significant @nhmrc grants totalling $9m to drive forward innovative approaches in #cancer treatment, lymphatic health and antimicrobial stewardship, led by @BenjaminHogan13, @monicaslavin and Prof Karin Thursky. More 👇 petermac.org/about-us/news-…
Wonderful work by @GemmaKReynolds queen of systematic rev and meta-analysis!
Infections in patients with lymphoma treated with bispecific antibodies: a systematic review and meta-analysis ow.ly/nLIA50Sy9Cp #clinicaltrialsandobservations #lymphoidneoplasia
A global call to encourage the use of standard reporting of infection AEs so we can advance research in the field. It was also mentioned at #ESCMIDGlobal2024
Consensus position statement on advancing the standardised reporting of infection events in immunocompromised patients [Sep 6, 2023] @benwteh et al. @TheLancetInfDis doi.org/10.1016/S1473-… #IDonc #leusm #lymsm #mmsm #mpnsm #caxtx
Infections following bispecific antibodies in myeloma: a systematic review and meta-analysis [Oct 10, 2023] @GemmaKReynolds et al. @benwteh @BloodAdvances ashpublications.org/bloodadvances/… #IDonc #mmsm #caxtx
#ECCMID2024 Hot topic 🔥 of developing AI tools for infection detection. Anna Khanina @NCICancer @NCAS_Aus explaining the laborious manual process and aiming for AI detection. Check out this cool dashboard for fungal infections IFIS!!! Coming soon
#ECCMID2024 Results from RCT of SD vs AD flu vaccine as a strategy for high-risk HM group by @victoriahall26 @NCICancer @benwteh showing no difference in primary outcome seroconversion but highlighting the CLL NHL groups as having poor responses in general. How to improve this?
Hot off the press - late breaking data from @victoriahall26 @NCICancer demonstrating similiar immunogenicity from two different vax strategies and no incremental benefit of second dose. #ESCMIDGlobal2024 #TxID
An amazing nation wide randomised trial of a simple reminder transforming vaccination uptake, even in immune compromised. Elegant solution. #ESCMIDGlobal2024 #TxID
Thanks for coming to our session. @NATBASH15 and i had fun with our talks. Hope it was useful! #ESCMIDGlobal2024 #TxID
Superb and hard work from @victoriahall26 PhD extraordinaire. Another impactful collab with @kedzierskalab . Will guide future long acting MoAb Prep practice. #TxID
Evolution of humoral and cellular immunity post breakthrough COVID-19 in vaccinated patients with hematologic malignancy receiving tixagevimab-cilgavimab ✅ Just Accepted 🔓 Open Access 🔗 bit.ly/46WUq7J @victoriahall26 @benwteh @monicaslavin @kedzierskalab @ncicancer
In light of updated MajesTEC-1 data at #IMS23 this week showing infection-related mortality of 12.7%(!), it is timely to see the nicely-formatted version of our systematic review just out in @BloodAdvances @GemmaKReynolds #mmsm @ManniMD1
sciencedirect.com/science/articl… 🔥 New article from @GemmaKReynolds @BeaCereus @monicaslavin @benwteh Systematic review and meta-analysis of infections in HM patients treated with CAR-T. Bacterial more common than viral or fungal post CAR-T, 17% developed serious infection.
Valuable contribution and leadership from the ASID ICH SIG #TxiD
Congratulations @benwteh - we posted this on the @ASIDANZ website. #showcase #membership asid.net.au/blog/developme…
United States Trends
- 1. $CUTO 7.283 posts
- 2. WNBA 38,7 B posts
- 3. Taina 5.458 posts
- 4. #WednesdayMotivation 6.615 posts
- 5. #wednesdayfeelings 2.250 posts
- 6. Good Wednesday 31,7 B posts
- 7. $ASTROS 2.166 posts
- 8. Dreamville 4.022 posts
- 9. #Alphabot 6.427 posts
- 10. Hump Day 16,6 B posts
- 11. #TheHeartKillersEP4 211 B posts
- 12. #WednesdayWisdom N/A
- 13. Herbo 1.779 posts
- 14. McConnell 72,6 B posts
- 15. $AUTOS 8.531 posts
- 16. Sports Illustrated Stadium N/A
- 17. $BOOST 9.313 posts
- 18. Core CPI 3.737 posts
- 19. USPS 21,2 B posts
- 20. Caitlin 56,6 B posts
Who to follow
-
Michelle Yong
@michyong2 -
NCIC
@NCICancer -
ASIDANZ
@ASIDANZ -
Joshua Davis
@Josh_S_Davis -
Abby Douglas
@AbbyPDouglas -
NCAS_Australia
@NCAS_Aus -
Tori Hall
@victoriahall26 -
Adam Stewart
@adm_stewart -
Dr David Griffin 🦠🧫💉
@drdavidwjg -
Brendan McMullan
@brendanmcID -
Jason Trubiano 🆔
@TrubianoJason -
transplantid.net
@TransplantIDNet -
Orla Morrissey
@OrlaMorris61218 -
Takahiro Matsuo (Taka), MD
@TakaMatsuo_ID -
Abhay Dhand
@DhandAbhay
Something went wrong.
Something went wrong.